1 search result for:

Agilent Technologies will sell Resolution Bioscience to Exact Sciences, a leading provider of cancer screening and diagnostic tests. Financial terms of the agreement were not disclosed. Resolution Bioscience develops and commercializes next-generation sequencing-based precision oncology solutions. Agilent acquired the company in 2021.